Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Douglas Onsi Insider Profile
11 Followers
Douglas Onsi, Director at Tetralogic Pharma, holds 0.00 shares in Tetralogic Pharma (Ticker: TLOG), holds 4.46M shares in Leap Therapeutics (Ticker: LPTX). Most recently, Douglas Onsi ― shares of Tetralogic Pharma on ― for an estimated value of ―.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-4.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Douglas Onsi holds in companies
Most Profitable Insider Trade
The most profitable trade made by Douglas Onsi
Douglas Onsi's Trading History
Tetralogic Pharma
―
Director
―
$0.00
Leap Therapeutics
Feb 05, 2019
CEO, Pres.,GC, Treas., & Sec., Director, Ten Percent Owner
Informative Buy
1000.00K
$7.09M
List of latest transactions for each holding click on a transaction to see Douglas Onsi's performance on stock
You May Also Like
Douglas Onsi insider profile FAQ
What is the percentage of profitable transactions made by Douglas Onsi?
The percentage of profitable transactions made by Douglas Onsi is 50%.
What is the average return per transaction made by Douglas Onsi?
The average return per transaction made by Douglas Onsi is -4.90%.
What stocks does Douglas Onsi hold?
Douglas Onsi holds: TLOG, LPTX stocks.
What was Douglas Onsi’s latest transaction?
Douglas Onsi latest transaction was an Uninformative Buy of ―.
What was Douglas Onsi's most profitable transaction?
Douglas Onsi’s most profitable transaction was an Informative Buy of LPTX stock on February 5, 2019. The return on the trade was 33.30%.
What is Douglas Onsi's role in Tetralogic Pharma?
Douglas Onsi's role in Tetralogic Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.